Return to search

Neuro23 takes in $100m Series C

Neuron23 Inc., a developer of precision medicines, has secured $100 million in Series C financing.

Neuron23 Inc., a developer of precision medicines, has secured $100 million in Series C financing. SoftBank Vision Fund 2 led the round.

Source: Press Release